Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:55 PM
Ignite Modification Date:
2025-12-24 @ 5:55 PM
NCT ID:
NCT01930968
Eligibility Criteria:
Inclusion Criteria:
* Adults 20 years old or over 18 years old with large uveal melanoma who are going to undergo enucleation
Exclusion Criteria:
* Patient with right-to-left, bi-direction, or transient right-to-left cardiac shunts
* Worsening of or clinically unstable congestive heart failure
* Acute myocardial infarctions or acute coronary syndromes
* Serious ventricular arrhythmias or high risk for arrhythmias, due to prolongation of the QT-interval (\>60 msec)
* Respiratory failures marked by signs and symptoms of CO2 retention or hypoxemia
* Severe emphysema, pulmonary emboli, or other conditions that cause pulmonary hypertension due to compromised pulmonary-arterial vasculature
* Known hypersensitivity to perflutren (if the patient has been exposed to perflutren in the past and had an allergic reaction)
* Pregnancy or nursing mothers
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT01930968
Study Brief:
Protocol Section:
NCT01930968